Edap Tms’ (EDAP) “Hold” Rating Reiterated at Jefferies Financial Group

Jefferies Financial Group reaffirmed their hold rating on shares of Edap Tms (NASDAQ:EDAP) in a report issued on Friday, MarketBeat reports. Jefferies Financial Group currently has a $2.00 price target on the medical equipment provider’s stock, down from their prior price target of $8.00.

A number of other equities research analysts have also recently commented on the stock. StockNews.com began coverage on shares of Edap Tms in a research note on Friday, March 28th. They set a “hold” rating on the stock. Piper Sandler dropped their price target on shares of Edap Tms from $5.00 to $4.50 and set an “overweight” rating on the stock in a research report on Friday, March 28th. Finally, HC Wainwright reiterated a “buy” rating and issued a $19.00 price objective on shares of Edap Tms in a research report on Friday, March 28th.

Edap Tms Stock Down 15.7 %

EDAP stock opened at $1.61 on Friday. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46. The firm’s fifty day simple moving average is $2.39 and its 200-day simple moving average is $2.46. Edap Tms has a 12 month low of $1.51 and a 12 month high of $8.50. The company has a market capitalization of $59.74 million, a P/E ratio of -2.48 and a beta of 0.37.

Edap Tms (NASDAQ:EDAP) last announced its quarterly earnings results on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.11) by $0.06. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. The company had revenue of $22.69 million for the quarter, compared to the consensus estimate of $20.83 million. As a group, equities research analysts forecast that Edap Tms will post -0.6 earnings per share for the current year.

Institutional Investors Weigh In On Edap Tms

Several institutional investors and hedge funds have recently added to or reduced their stakes in EDAP. Illumine Investment Management LLC acquired a new stake in shares of Edap Tms in the fourth quarter valued at about $50,000. BNP Paribas Financial Markets boosted its holdings in Edap Tms by 23.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock worth $59,000 after buying an additional 4,400 shares during the last quarter. Jane Street Group LLC increased its stake in Edap Tms by 174.7% during the 4th quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock worth $69,000 after buying an additional 73,361 shares in the last quarter. Millennium Management LLC raised its holdings in shares of Edap Tms by 218.5% during the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock valued at $108,000 after acquiring an additional 33,558 shares during the last quarter. Finally, Orion Capital Management LLC lifted its position in shares of Edap Tms by 10.4% in the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock valued at $178,000 after acquiring an additional 6,600 shares in the last quarter. Hedge funds and other institutional investors own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.